» Articles » PMID: 29126798

CD4 T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness

Overview
Journal Immunity
Publisher Cell Press
Date 2017 Nov 12
PMID 29126798
Citations 210
Authors
Affiliations
Soon will be listed here.
Abstract

CD4 T cells optimize the cytotoxic T cell (CTL) response in magnitude and quality, by unknown molecular mechanisms. We here present the transcriptomic changes in CTLs resulting from CD4 T cell help after anti-cancer vaccination or virus infection. The gene expression signatures revealed that CD4 T cell help during priming optimized CTLs in expression of cytotoxic effector molecules and many other functions that ensured efficacy of CTLs throughout their life cycle. Key features included downregulation of PD-1 and other coinhibitory receptors that impede CTL activity, and increased motility and migration capacities. "Helped" CTLs acquired chemokine receptors that helped them reach their tumor target tissue and metalloprotease activity that enabled them to invade into tumor tissue. A very large part of the "help" program was instilled in CD8 T cells via CD27 costimulation. The help program thus enhances specific CTL effector functions in response to vaccination or a virus infection.

Citing Articles

Identification and validation of a CD4 T cell-related prognostic model to predict immune responses in stage III-IV colorectal cancer.

Li M, Zhu W, Lu Y, Shao Y, Xu F, Liu L BMC Gastroenterol. 2025; 25(1):153.

PMID: 40069612 PMC: 11895157. DOI: 10.1186/s12876-025-03716-2.


Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells.

Sanlorenzo M, Novoszel P, Vujic I, Gastaldi T, Hammer M, Fari O Nat Cancer. 2025; 6(1):175-193.

PMID: 39849091 PMC: 11779648. DOI: 10.1038/s43018-024-00889-9.


FGL2 peptides improve the antitumor effect of HCMV-IE1mut vaccine against glioblastoma by modulating immunosuppressive cells in the tumor microenvironment.

Wang S, Jiang S, Li X, Huang H, Qiu X, Yu M Oncoimmunology. 2024; 13(1):2423983.

PMID: 39508842 PMC: 11542393. DOI: 10.1080/2162402X.2024.2423983.


Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy.

Liu H, Lu Y, Zong J, Zhang B, Li X, Qi H J Nanobiotechnology. 2024; 22(1):663.

PMID: 39465376 PMC: 11520105. DOI: 10.1186/s12951-024-02913-7.


CD4+ T cell help during early acute hepacivirus infection is critical for viral clearance and the generation of a liver-homing CD103+CD49a+ effector CD8+ T cell subset.

Lopez-Scarim J, Mendoza D, Nambiar S, Billerbeck E PLoS Pathog. 2024; 20(10):e1012615.

PMID: 39392861 PMC: 11498735. DOI: 10.1371/journal.ppat.1012615.